Cargando…
Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases
ERBB family receptor tyrosine kinases are overexpressed in a significant subset of breast cancers. One of these receptors, HER2/neu, or ErbB-2, is the target for a new rational therapeutic antibody, Herceptin. Other inhibitors that target this receptor, and another family member, the epidermal growt...
Autor principal: | Stern, David F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC138772/ https://www.ncbi.nlm.nih.gov/pubmed/11250707 http://dx.doi.org/10.1186/bcr51 |
Ejemplares similares
-
Negative regulation of ErbB family receptor tyrosine kinases
por: Sweeney, C, et al.
Publicado: (2004) -
The ErbB receptor tyrosine kinases and their roles in cancer
por: Hynes, NE
Publicado: (2003) -
Conformational changes in receptor tyrosine kinase signaling: an ErbB garden of delights
por: Carraway, Kermit L, et al.
Publicado: (2009) -
Peptide G-Protein-Coupled Receptors and ErbB Receptor Tyrosine Kinases in Cancer
por: Moody, Terry W., et al.
Publicado: (2023) -
Analysis of Somatic Mutations in Cancer: Molecular Mechanisms of Activation in the ErbB Family of Receptor Tyrosine Kinases
por: Shih, Andrew J., et al.
Publicado: (2011)